Peter Radovich

Senior Vice President-Operations at Global Blood Therapeutics, Inc.

Peter Radovich

Peter Radovich

Senior Vice President-Operations at Global Blood Therapeutics, Inc.

Overview
RelSci Relationships

150

Birthday

1978

Age

40

Relationships
RelSci Relationships are individuals Peter Radovich likely has professional access to. A relationship does not necessarily indicate a personal connection.

Partner at Mitchell Madison Group LLC

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Global Blood Therapeutics, Inc.

Relationship likelihood: Average

Senior Vice President, Research at Global Blood Therapeutics, Inc.

Relationship likelihood: Average

Senior Vice President, Clinical Development at Global Blood Therapeutics, Inc.

Relationship likelihood: Average

Chief Financial Officer at Global Blood Therapeutics, Inc.

Relationship likelihood: Average

Chief Legal Officer at Global Blood Therapeutics, Inc.

Relationship likelihood: Average

Chief Business & Strategy Officer at Global Blood Therapeutics, Inc.

Relationship likelihood: Average

Chief Accounting Officer at Global Blood Therapeutics, Inc.

Relationship likelihood: Average

Chief Medical & Chief Operating Officer at Provention Bio, Inc.

Relationship likelihood: Average

Former Chief Scientific Officer at Global Blood Therapeutics, Inc.

Relationship likelihood: Average

Paths to Peter Radovich
Potential Connections via
Relationship Science
You
Peter Radovich
Senior Vice President-Operations at Global Blood Therapeutics, Inc.
Education

Texas Christian University (TCU) is a private, coeducational university located in Fort Worth, Texas. The campus is located on 272 acres (1.10 km2) about three miles (8 km) from downtown Fort Worth. TCU is affiliated with, but not governed by, the Disciples of Christ. Its mascot is the "horned frog", and women's teams are known as the Lady Frogs. For most varsity sports TCU competes in the Big 12 conference of the NCAA's Division I. The university enrolls around 9,725 students, with 8,456 being undergraduates. As of October 2011, TCU's total endowment was $1.2 billion.

Career History
Senior Vice President-Operations
2014 - Current

Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.

Vice President-Program Leadership
2004 - 2006

Based in South San Francisco, California, Onyx Pharmaceuticals, Inc. is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer. At Onyx, we are grounded in three leadership hallmarks that guide how we manage our business and build value for patients and shareholders: innovation, patient-centeredness and stewardship.

Professional
Prior

Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA.

Public Holdings
Restricted data only for RelSci Professional users.
Other Affiliations